What is the incidence of peripheral neuropathy in patients treated with bortezomib for TTP, and how does it affect treatment outcomes?
Abstract
Bortezomib treatment can lead to significant peripheral neuropathy, affecting treatment outcomes, although the exact incidence rates vary widely. Treatment cessation or modifications can sometimes ameliorate symptoms, but specific data for bortezomib use in TTP is limited.
Fields of Study & Subjects
Cancer Treatment and Pharmacology
Multiple Myeloma Research and Treatments
Peripheral Neuropathies and Disorders
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 29 January 2026